Multidrug resistance — a multiplex phenomenon

1. Gottesman, M.M. & Pastan, I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62, 385−427 (1993). | Article | PubMed  | ISI | ChemPort |
2. Chabner, B.A. & Fojo, A. Multidrug resistance: P-glycoprotein and its allies —; the elusive foes. J. Natl. Cancer Inst. 81, 910−913 (1989). | PubMed  | ChemPort |
3. Bargou, R.C. et al. Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression. Nature Med. 4, 447−450 (1997).
4. Cordon-Cardo, C. et al. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J. Histochem. Cytochem. 38, 1277−1287 (1990). | PubMed  | ChemPort |
5. van Kalken, C.K. et al. Multidrug resistance gene (P-glycoprotein) expression in the human fetus. Am. J. Pathol. 141, 1063−1072 (1992). | PubMed  | ChemPort |
6. Baldini, N. et al. Nuclear immunolocalization of P-glycoprotein in multidrug resistant cell lines showing similar mechanisms of doxorubicin distribution. Eur. J. Cell Biol. 68, 226−239 (1995). | PubMed  | ISI | ChemPort |
7. Valverde, M.A. et al. Volume-regulated chloride channels associated with the human multidrug-resistance P-glycoprotein. Nature 355, 830−833 (1992). | Article | PubMed  | ISI | ChemPort |
8. Abrahams, E.H. et al. The multidrug resistance (mdr1) gene product functions as an ATP channel. Proc. Natl. Acad. Sci. USA 90, 312−316 (1993). | PubMed  | ChemPort |
9. Goldstein, L.J. et al. Expression of a multidrug resistance gene in human cancers. J. Natl. Cancer Inst. 81, 116−124 (1989). | Article | PubMed  | ChemPort |
10. Biedler, J.L. & Spengler, B.A. Reverse transformation of multidrug-resistant Cells. Cancer Metastasis Rev. 13, 191−207 (1994). | PubMed  | ISI | ChemPort |
11. Bradley, G. & Ling, V., P-glycoprotein, multidrug resistance and tumor progression. Cancer Metastasis Rev. 13, 223−233 (1994). | PubMed  | ISI | ChemPort |
12. Linn, S.C. et al. p53 and P-glycoprotein are often co-expressed and are associated with poor prognosis in breast cancer. Br. J. Cancer 74, 63−68 (1996). | PubMed  | ISI | ChemPort |
13. Chin, K.-V., Ueda, K., Pastan, I. & Gottesman, M.M. Modulation of activity of the promoter of the human MDR1 gene by Ras and p53. Science 255, 459−462 (1992). | PubMed  | ISI | ChemPort |
14. Kohno, K. et al. Cellular control of human multidrug resistance 1 (mdr-1) gene expression in absence and presence of gene amplification in human cancer cells. J. Biol. Chem. 269, 20503−20508 (1994). | PubMed  | ISI | ChemPort |
15. Goldsmith, M.E., Madden, M.J., Morrow, C.S. & Cowan, K.H. A Y-box consensus sequence is required for basal expression of the human multidrug resistance (MDR1) gene. J. Biol. Chem. 268, 5856−5860 (1993). | PubMed  | ISI | ChemPort |
16. Wolffe, A.P. Structural and functional properties of the evolutionarily ancient Y-box family of nucleic acid binding proteins. BioEssays 16, 245−251 (1994). | PubMed  | ISI | ChemPort |
17. Ladomery, M. & Sommerville, J. A role for Y-box proteins in cell proliferation. BioEssays 17, 9−11 (1995). | PubMed  | ISI | ChemPort |
18. Scotlandi, K. et al. Multidrug resistance and malignancy in human osteosarcoma. Cancer Res. 56, 2434−2439 (1996). | PubMed  | ISI | ChemPort |

	Top

	Top